Starting on:
Oct 3, 2022
Ending on:
Nov 9, 2022
Moderator(s):
Venue:
Virtual-ICI
Max Credits:
10 Points
Provider:
International Cancer Institute
Claim Points
Oct 3, 2022
Ending on:
Nov 9, 2022
Moderator(s):
Virtual-ICI
Max Credits:
10 Points
Provider:
International Cancer Institute
Claim Points
Breast Cancer Preceptorship (CBP 105)
Starting on:
Oct 3, 2022 4:00 PM
Oct 3, 2022 4:00 PM
Ending on:
Nov 9, 2022 5:30 PM
Nov 9, 2022 5:30 PM
Venue:
Virtual-ICI
Virtual-ICI
Description
International Cancer Instituteâ??s Preceptorship Courses aim to leverage the expertise of its Faculty to help clinicians understand best practices in the diagnosis and management of conditions encountered in the clinical setting in sub-Saharan Africa.
Objectives
At the end of this educational activity, participants should be able to: 1. Understand the Epidemiology of Breast cancer in sub-Saharan Africa (SSA) 2. Discuss breast cancer screening, risk factors, and protective factors associated with breast cancer 3. Recognize the role of pathological diagnosis, staging, molecular subtypes, the prognostic and therapeutic significance of tumor estrogen receptor, progesterone receptor, and human epidermal growth factor receptor 2 expressions for breast cancer 4. Interpret mammograms and appreciate the role of radiology in breast cancer management 5. To review the optimal treatment strategies for Breast cancer: chemotherapy, hormonal, targeted agents, and monoclonal antibodies. 6. Describe the current trends in the locoregional and systemic management of operable early-stage breast cancer. 7. To understand the role of the multidisciplinary team in Breast cancer management 8. To understand the role of Surgery in the management of Breast cancer 9. To understand the role of radiotherapy in the management of breast cancer 10. To recall the current goals and standard of care in the management of metastatic breast cancer. 11. To recognize the existence of breast cancer in male patients 12. To understand the role of Palliative, supportive, and survivorship care in Breast cancer management 13. To discuss the role and integration of Biosimilars in breast cancer management 14. Appreciate the research priority areas in breast cancer in SSA
Presenters
-
Dr.
Siwillis Mithe
Clinical Oncologist
Nakuru Provincial General Hospital -
Dr.
Helena Musau
Clinical Oncologist
Meru Teaching and Referral Hospital -
Dr.
Shaheen Sayed
Pathologist
Aga Khan University Hospital -
Dr.
Irene Weru
Pharmacist
Kenyatta National Hospital -
Dr.
Abdu Adem
Clinical Oncologist
St. Paul's Millenium Hospital, Ethiopia -
Dr.
Benjamin Njihia
General Surgeon
St. Francis Community Hospital, Nairobi -
Dr.
Helena Musau
Clinical Oncologist
Meru Teaching and Referral Hospital -
Dr.
Sitna Mwanzi
Medical Oncologist
Aga Khan University Hospital -
Dr.
Zipporah Ali
Palliative Care Specialist
Executive Director of Kenya Hospices and Palliative Care Association (KEHPCA). -
Dr.
Kevin Makori
Clinical and Radiation Oncologist
International Cancer Institute -
Dr.
David Wata
Pharmacist
Kenyatta National Hospital -
Prof.
Fredrick Chite
Medical Oncologist & Hematologist
International Cancer Institute -
Prof.
Emmanuel Rudakemwa
Clinical Oncologist
University of Global Health Equity